Sarepta Therapeutics, Inc., the leader in precision genetic medicine for rare diseases, granted equity awards on October 29, 2021 that were previously approved by the Compensation Committee of its Board of Directors under Sarepta’s 2014 Employment Commencement Incentive Plan, as a material inducement to employment to 17 individuals hired by Sarepta in October 2021.
October 29, 2021
· 2 min read